(Q48700510)

14 February 2018

title

Magnesium sulfate effectively reduces blood pressure in an animal model of preeclampsia (English)

1 reference

14 February 2018

0 references

0 references

0 references

1 reference

Cynthia A Standley

1

1 reference

14 February 2018

Lyn Batia

series ordinal

2

1 reference

14 February 2018

Gloria Yueh

series ordinal

3

1 reference

14 February 2018

publication date

1 March 2006

1 reference

14 February 2018

Journal of Maternal-Fetal and Neonatal Medicine

published in

1 reference

14 February 2018

volume

19

1 reference

14 February 2018

issue

3

1 reference

14 February 2018

page(s)

171-176

1 reference

14 February 2018

Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

Marked variation in responses to long-term nitric oxide inhibition during pregnancy in outbred rats from two different colonies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

Serum ionized magnesium levels in normal and preeclamptic gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

Etiology and pathogenesis of preeclampsia: current concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

Favorable hemodynamic effects of magnesium sulfate in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

Effects of blood pressure on orbital and middle cerebral artery resistances in healthy pregnant women and women with preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

Pharmacokinetic-pharmacodynamic modelling of magnesium plasma concentration and blood pressure in preeclamptic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

Tissue and blood levels of zinc, copper, and magnesium in nitric oxide synthase blockade-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

Magnesium sulfate therapy in preeclampsia is associated with increased urinary cyclic guanosine monophosphate excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

The teratogenicity of N(omega)-nitro-L-ariginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

Magnesium sulfate attenuates peroxide-induced vasoconstriction in the human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050500448005

10.1080/14767050500448005

21 January 2018

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018